Christian Eckman

Christian Eckmann serves as Head of the Department of General, Visceral and Thoracic Surgery and ABS Team Lead at Klinikum Hannoversch-Muenden in Germany.  He is Professor for Clinical Research in Surgical Infections at Luebeck University, Germany. He became Professor of Surgery in 2014 and was certified as Antibiotic Stewardship Expert (ECDC/DGKH) in 2016. He was awarded in 2019 as fellow of the International Society for Antimicrobial Chemotherapy (FISAC) for outstanding professional contributions.

Prof. Eckmann is head of the intra-abdominal infections section of the expert panel for the German national guidelines for antimicrobial treatment of infections. He is member of the Executive Committee of the Paul-Ehrlich Society for Chemotherapy (PEG) and the Working Group Critically Ill Patients (ESGCIP) of ESCMID.

His scientific interests include complicated intra-abdominal infections and complicated skin and soft tissue infections due to resistant bacteria, fungi and Clostridioides difficile. Since 2012 he is involved in scientific projects about health care economics (early switch and early discharge strategies) in Infectious Diseases in different health care settings. Prof Eckmann has published over 150 articles for peer-reviewed journals and more than 25 book articles. He received the Julius-Springer-Award in 2017 and 2019 for the best published manuscript in the journal “Der Chirurg” (The Surgeon). In 2019, he was appointed as a member of the Editorial Board of the Journal of Acute Care Surgery.

Currently he is working as a member of an expert panel for Cornell University, New York on the topic of risk factors for mortality in necrotizing soft tissue infections.

He is a member of the following guidelines: Perioperative antibiotic prophylaxis in patients colonized with multidrug resistant gram-positive and gram-negative bacteria (ESCMID), diagnosis and treatment of diverticular disease, perioperative antibiotic prophylaxis, treatment of infections due to multidrug-resistant bacteria, calculated antimicrobial therapy in adults suffering from bacterial infections.